Hepatology communicationsHumansCarcinomaHepatocellularLiver NeoplasmsMale
Differential survival benefit of curative versus non-curative intent treatment in a real-world cohort with early and intermediate-stage hepatocellular carcinoma.
David Goldberg, Binu John, David Kaplan, Cindy Delgado, Neelima Gaddipati, Sirisha Gaddipati, Catherine Blandon
Published: 202610.1097/HC9.0000000000000891
Abstract
BACKGROUND: Treatment algorithms for hepatocellular carcinoma (HCC) account for tumor burden/stage and severity of liver disease. There are conflicting data on the differential benefit of curative versus non-curative treatments based on BCLC stage. T…
Preview only. Read the full abstract at the source